Cardiac troponin T elevation after coronary artery bypass grafting is associated with increased one-year mortality.
The results of the present study extend the value of assessing troponin T for the prediction of mortality rate 1 year after coronary artery bypass grafting; this study supports previous work that demonstrated the value of postoperative assessment of troponin T for the prediction of in-hospital adverse outcome after coronary artery bypass grafting.
Cardiology Division, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.
Sekar
S
Kathiresan
Stephen J
SJ
Servoss
John B
JB
Newell
Dawn
D
Trani
Thomas E
TE
MacGillivray
Kent
K
Lewandrowski
Elizabeth
E
Lee-Lewandrowski
James L
JL
Januzzi
D000368:Aged; D015415:Biomarkers / Q000097:blood; D001900:Boston; D001026:Coronary Artery Bypass; D003327:Coronary Disease / Q000097:blood* / Q000401:mortality / Q000601:surgery*; D003402:Creatine Kinase / Q000097:blood; D052279:Creatine Kinase, MB Form; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007527:Isoenzymes / Q000097:blood; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D011183:Postoperative Complications / Q000097:blood / Q000209:etiology* / Q000401:mortality*; D011237:Predictive Value of Tests; D011446:Prospective Studies; D013223:Statistics as Topic; D016019:Survival Analysis; D013997:Time Factors; D016896:Treatment Outcome; D020107:Troponin T / Q000378:metabolism*
D015415:Biomarkers; D007527:Isoenzymes; D020107:Troponin T; D003402:Creatine Kinase; D052279:Creatine Kinase, MB Form